Every funding round in India begins with a question most founders answer too quickly: What instrument is this money coming in on? The answer decides who controls conversion, what happens if the next round is late, and whether your structure survives the due diligence that follows. This guide breaks down the four instruments that paper Indian early-stage rounds, what changed in 2025-26, and a framework for choosing the right one before the term sheet is signed.
Table of Contents
The short answer
Your early-stage round in India will be papered as a convertible note, CCPS, CCD, or iSAFE. They are not interchangeable. The right choice is dictated by four variables: your DPIIT status, your investor’s profile, whether you are deferring valuation, and your cheque size. Pick wrong, and you inherit a debt overhang, a FEMA pricing problem, or a cap table you will spend the next round cleaning up.
The comparison at a glance
| Convertible Note | CCPS | CCD | iSAFE / SAFE | |
|---|---|---|---|---|
| Legal nature | Debt, optionally convertible | Preference shares, compulsorily convertible | Debenture, compulsorily convertible | Contractual right that resolves into CCPS |
| Conversion | Holder’s option, or repaid | Mandatory | Mandatory | Mandatory CCPS on trigger |
| Who can issue | DPIIT startups only | Any company | Any company | Any company (via CCPS) |
| Minimum ticket | ₹25 lakh per investor | None | None | None |
| Valuation fixed upfront? | No | Yes (priced round) | Price/formula set upfront | No |
| Interest / yield | Optional | Dividend, if declared | Yes, interest bearing | None |
| Foreign investors (FDI) | Automatic route; FEMA pricing on conversion | Cleanest equity instrument | Clean equity instrument | Via CCPS; raw SAFE not recognised |
| Best for | DPIIT startups deferring valuation | Priced VC rounds | Yield-seeking / structured investors | Fast angel and accelerator rounds |
| Primary risk | Debt overhang if it never converts | Negotiated preferential rights | Interest cost + IBC debate | Drafting drift from Companies Act/FEMA |
The four instruments, briefly
Convertible Note. Money taken initially as debt that converts at a future priced round, or is repaid. In India, it is a privileged instrument, not a default: Only startups with DPIIT recognition and company registration in order can issue one, with a ₹25 lakh minimum per investor and up to 10 years to convert or repay. Its risk lives in the word optionally: Because the holder can demand repayment, an unconverted note is a liability on your balance sheet at exactly the moment you can least afford it.
CCPS. Compulsorily Convertible Preference Shares are the workhorse of the Indian venture round and the instrument institutional investors expect. They must convert, which gives both sides a cap table they can trust, and they carry the negotiated rights that define a deal: liquidation preference, anti-dilution, dividend, and governance rights, all documented in the shareholders’ agreement and deal contracts. For foreign capital, they are the cleanest equity instrument under FEMA, and conversion into equity is not a taxable transfer under Section 47 of the Income Tax Act, a point worth locking in as part of tax-efficient deal structuring.
CCD. Compulsorily Convertible Debentures sit closest to debt while remaining an equity instrument for FDI. They must convert, but they carry interest, which is the point: The investor earns a yield while waiting. That interest is also the cost: It is taxable in the investor’s hands, creating TDS compliance obligations for the company, and attracting withholding tax for a cross-border investor.
SAFE and iSAFE. A US SAFE is not recognised under the Indian Companies Act or FEMA. The compliant Indian version is the iSAFE, structured to issue CCPS on a trigger event. It carries no ₹25 lakh floor, which is why it works for angel cheques a convertible note cannot. The catch: An iSAFE is only as compliant as its drafting, which is why founders typically have the instrument papered under specialist fundraising advisory, because it must satisfy the Companies Act and, where money is foreign, FEMA pricing and reporting compliance.
Get answers from startup legal experts, not after the problem, but before it.
The 2025-26 shift you must price in: Angel tax is gone, FEMA is not
For twelve years, this decision was distorted by angel tax under Section 56(2)(viib), which taxed share premium above fair market value at roughly 31%, paid by the company out of the capital it had just raised. That era is over. The Finance Act, 2024 abolished angel tax for all classes of investors, resident and non-resident, with effect from FY 2025-26 (1 April 2025).
Here is where sophisticated founders separate themselves: Abolition does not end valuation discipline. Two things still bite. First, FEMA fair-value pricing: Where a foreign investor is involved, shares still cannot be issued below fair value certified through a valuation report. Second, legacy assessments: Raises before 1 April 2025 can still be reopened, so keep your valuation reports, board resolutions, and ROC filings in order. The tax distortion is gone, which means the instrument can finally be chosen on its merits.
The decision framework
Strip away the jargon, and the choice resolves to five questions.
- Are you DPIIT-recognised?
If yes, the convertible note is available. If no, you are choosing between CCPS, CCD, and iSAFE.
- Is the money foreign?
If yes, default to CCPS or CCD, the cleanest FDI equity instruments. Never use an optionally convertible instrument for foreign money; it is not eligible FDI equity and will be treated as external debt.
- Are you deferring valuation?
If yes, use a convertible note (if DPIIT-recognised) or an iSAFE. If you are running a priced round, use CCPS.
- How large is the cheque?
Below ₹25 lakh, the note is unavailable, so use an iSAFE. At or above, the note is in play.
- Does the investor want a yield while they wait?
If yes, a CCD delivers interim interest. If not, CCPS or a note is cleaner.
Run those five, and the instrument chooses itself. The art is in the terms that sit on top: the valuation cap, discount, conversion mechanics, and preferential rights. That is where the next three years of your cap table are quietly decided.
Five structuring mistakes that surface in due diligence
The same failures appear round after round, and every one of them is cheap to prevent and expensive to cure.
- 1. Copy-pasting a US SAFE into an Indian round. It has no standing under the Companies Act or FEMA. Map it to a convertible note, CCPS, or iSAFE before any money moves.
- 2. Splitting a cheque to dodge the ₹25 lakh convertible note minimum. The minimum applies per investor, per tranche. Engineering around it invites a reclassification as a deposit, which is a far worse problem than the one you were avoiding.
- 3. Leaving the conversion price open-ended for foreign investors. Where the money is foreign, a price or formula must be fixed at issue, and the conversion must meet fair-value norms. “We will figure it out later” is not a structure.
- 4. Using optionally convertible instruments for foreign capital. OCPS and OCDs are not eligible FDI equity instruments and will be treated as external debt. This is one of the most common and most expensive errors in cross-border seed rounds.
- 5. Treating angel tax abolition as the end of valuation discipline. Abolition removed one floor and left the FEMA floor standing. Cross-border deals still need a defensible, certified valuation.
The cost of these mistakes is rarely the legal fee to fix them. It is the deal momentum lost while you unwind a structure mid-round, with an investor watching.
Frequently Asked Questions
Which fundraising instrument is best for Indian startups?
There is no single best instrument. Priced venture rounds use CCPS; valuation-deferred angel rounds use a convertible note (if DPIIT-recognised) or an iSAFE; investors wanting an interim yield use CCDs.
Is a US-style SAFE legal in India?
A US SAFE is not recognised under the Indian Companies Act or FEMA. The compliant equivalent is the iSAFE, structured to issue CCPS on a trigger event.
Has angel tax been abolished?
Yes. Section 56(2)(viib) is abolished for all investor classes from FY 2025-26 (1 April 2025). Pre-April 2025 raises can still be assessed, and FEMA fair-value pricing continues to apply to foreign investment.
What is the minimum investment for a convertible note in India?
₹25 lakh per investor in a single tranche. Rounds below that typically use an iSAFE, which has no statutory minimum.
Can a startup that is not DPIIT-recognised issue a convertible note?
No. Convertible notes are available only to DPIIT-recognised startups. A non-recognised company chooses between CCPS, a CCD, or an iSAFE structured to issue CCPS.
The structure is the strategy
Founders who win their rounds do not treat the instrument as paperwork. They treat it as the first negotiation, because the instrument decides who controls conversion, what happens if the next round is late, and whether the structure survives the diligence that follows. Get it right, and the round closes clean. Get it wrong, and you meet the consequences at exactly the moment you have the least leverage to fix them. That is the difference between drafting documents and architecting deals.
The Startup Gig is a venture deal advisory firm integrating legal, financial, tax, and governance counsel. This article is for general information and does not constitute legal, tax, or financial advice; instrument selection should be confirmed against your specific facts and the law in force at the time of your transaction.